# Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sintilimab-versus-placebo-in-combination-with-chemotherapy-as-first-line/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Zhihao Lü,Junye Wang,Yongqian Shu,Lianke Liu,Li Ren Kong,Lei Yang,Buhai Wang,Guogui Sun,Yinghua Ji,Guochun Cao,Hu Liu,Tongjian Cui,Na Li,Wensheng Qiu,Gaofeng Li,Xinfang Hou,Hui Luo,Liying Xue,Yanqiao Zhang,Wenbin Yue,Zheng Liu,Xiuwen Wang,Shegan Gao,Yueyin Pan,Marie‐Pierre Galais,Aziz Zaanan,Zhuo Ma,Haoyu Li,Yan Wang,Lin Shen |
| Citations | 493 |
| DOI | 10.1136/bmj-2021-068714 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.bmj.com/content/bmj/377/bmj-2021-068714.full.pdf |
| OpenAlex ID | https://openalex.org/W4224260137 |
| PMID | 35440464 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Yueyin Pan](https://scholariq.org/researchers/yueyin-pan/)

## Paper journal

- [BMJ](https://scholariq.org/journals/bmj-2/)

## Paper primary topic

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

## Paper topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.